Navigation Links
Shellgel 1.2% Sodium Hyaluronate

ProductsShellgel 1.2% Sodium Hyaluronate
Company Cytosol Ophthalmics
Item Shellgel 1.2% Sodium Hyaluronate
Features SHELLGEL is intended for use during surgery in the anterior and posterior segments of the human eye. Procedures include:
  • Cataract extraction
  • Intraocular lens (IOL) implantation
  • Corneal transplantation surgery
  • Glaucoma filtering surgery
  • Surgical procedures to reattach the retina
Description SHELLGEL is a sterile nonpyrogenic, transparent viscoelastic solution of highly purified sodium hyaluronate. SHELLGEL contains 12 mg/mL of high molecular weight (greater than 1 million daltons) sodium hyaluronate dissolved in physiological saline. In the limit of zero shear rate, the viscosity is 105,000 cps (105 Pa s) at 25C, and the osmolality is approximately 320 milliosmols. Sodium hyaluronate is a naturally occurring polysaccharide composed of sodium glucuronate and N-acetylglucosamine found throughout the tissues of both man and animals. SHELLGEL is prepared from the dermis of rooster combs.

SHELLGEL is a sterile viscoelastic preparation supplied in a disposable glass syringe delivering 0.8 mL of sodium hyaluronate dissolved in physiological saline. Each mL contains 12 mg of sodium hyaluronate, 9 mg of sodium chloride and q.s. sterile water for injection USP. Sodium hydroxide and or hydrochloric acid are used to adjust pH (if necessary). SHELLGEL is sterile filtered and aseptically transferred to syringes. The filled syringes are sealed and the final packaging is sterilized by irradiation. Contents are sterile and nonpyrogenic in unopened and undamaged pouches.

Info Cytosol Ophthalmics
Customer Service: (800) 234-5166
Web site: http://www.cytosol.com/

Related medicine products :

1. SAFE-T-FILL Blood Gas Capillary Tubes Sodium Heparin
2. SAFE-T-FILL Sodium Fluoride
3. BD Vacutainer® Specialty Tubes - Sodium Polyanetholesulfonate (SPS)
4. Sodium
5. Sodium, Fecal
6. Sodium, Fluid
7. Sodium, Plasma or Serum
8. Sodium, Urine
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 1KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 2KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 3KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 4KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 5KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 6Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 1Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 2Alzheimers Soars Global Focus Needed 3A Study 57748 1Alzheimers Soars Global Focus Needed 3A Study 57748 2Alzheimers Soars Global Focus Needed 3A Study 57748 3